1H-imidazole derivatives as cannabinoid receptor modulators

Details for Australian Patent Application No. 2004283903 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Van Stuivenberg, Herman H.; Lange, Josephus H.M.; Kruse, Cornelis G.; Keizer, Hiskias G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004283903

PCT Pub. Number WO2005/040130

Priority 03103867.2 20.10.03 EP; 60/512,105 20.10.03 US

Filing date 19 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 2 December 2010

International Classifications

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/040130 Priority application(s): WO2005/040130

2 December 2010 Application Accepted

  Published as AU-B-2004283903

31 March 2011 Standard Patent Sealed

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283907-Form-and-seal unit for a machine for packaging pourable food products

2004283896-Reclosable rigid container assembly